ClinicalTrials.Veeva

Menu

Exploring the Role of 3T MRI in Gamma Knife Radiosurgery

University Health Network, Toronto logo

University Health Network, Toronto

Status

Completed

Conditions

Brain Metastases

Study type

Observational

Funder types

Other

Identifiers

NCT00602992
06-0427-CE

Details and patient eligibility

About

Gamma Knife radiosurgery is a non-invasive technique for the delivery of a single, high dose of radiation to an intra-cranial target. MRI has an established and central role in the treatment planning process and assessment of response to intracranial radiosurgery. Increasing the field strength of MRI from 1.5T to 3T promises to improve the signal, and in turn the quality of images. However, the technology also introduces new limitations, and the role and safety of 3T MRI in the management of patients receiving radiosurgery has not yet been reported. In this pilot study, we will explore the spatial integrity, and incremental image-guidance utility of 3T MRI in patients receiving radiosurgery. The preliminary data acquired in this study will be instrumental to the judicious design and conduct of subsequent definitive clinical trials. Up to fifty patients will be enrolled in this study.

Enrollment

45 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients planned to receive Gamma Knife radiosurgery will be eligible for enrollment on this study.

Exclusion criteria

  • Age<18
  • Contra-indications to 3T MRI, such as implanted metal devices or shrapnel.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems